Published July 2003 | Version v1
Journal article

MRI in methotrexate-related leukoencephalopathy: Disseminated necrotising leukoencephalopathy in comparison with mild leukoencephalopathy

  • 1. Department of Radiology, St Luke's International Hospital, 9-1 Akashi-cho Chuo-ku, 104-8560, Tokyo (Japan)
  • 2. Department of Radiology, Hokkaido Graduate University School of Medicine, 060-8638, Sapporo (Japan)
  • 3. Department of Paediatrics, Hokkaido Graduate University School of Medicine, 060-8638, Sapporo (Japan)
  • 4. Department of Neurosurgery, Hokkaido Graduate University School of Medicine, 060-8638, Sapporo (Japan)

Description

We report two fatal cases of methotrexate (MTX)-induced disseminated necrotising leukoencephalopathy (DNL) in which MRI was repeated from the onset. Initial T2-weighted images showed multiple areas of high signal, mainly in deep cerebral white matter, which on follow-up, spread and coalesced to involve the entire white matter. Small irregular low-signal foci on T2-weighted images were seen within the high-signal lesions. Multiple areas of contrast enhancement corresponded to these low-signal foci. The condition of both patients deteriorated and they died. We compared their MRI findings with those of seven patients with mild MTX-related leukoencephalopathy, six of whom were asymptomatic; one had transient neurological symptoms. They showed no contrast enhancement, but rather mild-to-moderate diffuse high signal in deep white matter, which later disappeared. These findings suggest that multiple low-signal foci on T2-weighted images with contrast enhancement may be characteristic of DNL, and that contrast-enhanced imaging is useful to differentiate this condition from mild leukoencephalopathy. (orig.)

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00234-003-0983-3

Additional details

Identifiers

Publishing Information

Journal Title
Neuroradiology
Journal Volume
45
Journal Issue
7
Journal Page Range
p. 493-497
ISSN
0028-3940
CODEN
NRDYAB